Search
forResearch 10 of 40
- QR 678 & QR678 Neo Vs PRP—A randomised, comparative, prospective study
- QR678 & QR678 Neo Hair Growth Formulations: A Cellular Toxicity & Animal Efficacy Study
- Efficacy of QR678 Neo<sup>®</sup> hair growth factor formulation for the treatment of hair loss in Covid‐19‐induced persistent Telogen Effluvium—A prospective, clinical, single‐blind study
- Effectiveness of QR678 and QR678 Neo <sup>®</sup> with intralesional corticosteroid vs. intralesional corticosteroid alone in the treatment of alopecia areata –A randomized, comparative, prospective study
- Evaluation of efficacy of intradermal injection therapy vs derma roller application for administration of QR678 Neo <sup>®</sup> hair regrowth formulation for the treatment of Androgenetic Alopecia—A prospective study
- Evaluation of efficacy of QR 678 and QR678 neo hair growth factor formulation for the treatment of female pattern alopecia in patients with PCOS—A prospective study
- Evaluation of the safety and effectiveness of intradermal administration of QR678 Neo<sup>®</sup> hair growth factor formulation: A phase‐IV, open‐label, single‐arm multi‐ethnicity clinical trial
- Comparison between QR678 neo and platelet rich plasma for hair growth -A retrospective study
- A newer approach in the treatment of seborrheic dermatitis with QR678® and QR678 Neo®—A prospective pilot study
- “Comparison of QR 678 ® & QR678 ® Neo as monotherapy and as combination therapy with 5% Minoxidil solution and oral Finasteride in the treatment of male androgenetic alopecia—Which is better?”
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →